ANIP

ANI Pharmaceuticals Inc

ANIP.US anipharmaceuticals.com + Research + Basket
CIK 0001023024
Employees 970
Phone 218 634 3500
Fiscal year end December
IPO May 05, 2000
Address 210 Main Street West, Baudette, MN, United States, 56623
69.62
-2.03 (-2.83%)
USD · NASDAQ
52-week range
69.58
95.45
Trading at 0% of the 52-week range
Market Cap
1.65B
P/E Ratio
15.51
Forward P/E
7.14
Book Value
27.87
Div. Yield
N/A
% Institutions
107.19%
% Insiders
5.37%

1 Year

-24.8%

3 Year

+10.6%

10 Year

+31.8%
Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Actions

Add an action for ANIP.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Nikhil Lalwani President, CEO & Director 1978
Mr. Stephen P. Carey Senior VP of Finance & CFO 1971
Ms. Meredith W. Cook J.D. Senior VP, General Counsel & Corporate Secretary 1974
Mr. Christopher K. Mutz Senior VP & Head of Rare Disease 1972
Mr. Ori Gutwerg Senior Vice President of Generics 1975
Mr. Muthusamy Shanmugam MS R.Ph. Head of R&D and COO of New Jersey Operations 1968
Ms. Irina Rivkind Koffler Vice President of Investor Relations NA
Ms. Elizabeth Powell J.D. Chief Compliance Officer & Head of Legal of Rare Disease NA
Mr. Chad Gassert Senior Vice President of Corporate Development & Strategy 1976
Ms. Krista L. Davis Senior VP & Chief Human Resources Officer 1973

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Apr 13, 2026 Meredith Cook N/A Sale 500.00 $77.95 $38.98K SEC
Mar 13, 2026 Meredith Cook N/A Sale 500.00 $72.62 $36.31K SEC
Mar 13, 2026 Christopher Mutz N/A Sale 3.16K $71.64 $226.53K SEC
Mar 11, 2026 Thomas Andrew Rowland N/A Sale 4.77K $74.91 $357.47K SEC
Mar 05, 2026 Stephen P Carey N/A Sale 7.31K $75.50 $552.06K SEC
Mar 03, 2026 Ori Gutwerg N/A Sale 2.06K $76.50 $157.59K SEC
Mar 02, 2026 Christopher Mutz N/A Sale 417.00 $74.00 $30.86K SEC
Feb 20, 2026 Christopher Mutz N/A Sale 5.32K $78.02 $415.30K SEC
Feb 20, 2026 Krista Davis N/A Sale 1.73K $77.99 $134.92K SEC
Feb 19, 2026 Krista Davis N/A Sale 2.08K $77.53 $161.57K SEC
Jan 13, 2026 Meredith Cook N/A Sale 500.00 $84.33 $42.17K SEC
Dec 18, 2025 Krista Davis N/A Sale 1.62K $82.40 $133.65K SEC
Dec 12, 2025 Meredith Cook N/A Sale 400.00 $82.32 $32.93K SEC
Dec 05, 2025 Renee P Tannenbaum N/A Sale 1.80K $81.15 $146.07K SEC
Nov 13, 2025 Chad Gassert N/A Sale 94.00 $88.00 $8.27K SEC
Nov 13, 2025 Meredith Cook N/A Sale 400.00 $87.27 $34.91K SEC
Nov 13, 2025 Patrick D Walsh N/A Sale 8.64K $86.88 $750.90K SEC
Nov 12, 2025 Chad Gassert N/A Sale 14.64K $89.07 $1.30M SEC
Oct 13, 2025 Meredith Cook N/A Sale 400.00 $90.09 $36.04K SEC
Sep 19, 2025 Krista Davis N/A Sale 1.00K $98.04 $98.04K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 2.96M Jun 30, 2026 12.88% $0.00 7.69%
Soleus Capital Management, L.P. 867.76K Jun 30, 2026 3.78% $2.48 5.79%
Vanguard Capital Management, LLC 838.22K Jun 30, 2026 3.65% $0.00 1.84%
State Street Corp 831.65K Jun 30, 2026 3.62% $0.00 7.78%
TANG CAPITAL MANAGEMENT LLC 707.50K Jun 30, 2026 3.08% $2.66 0.00%
Dimensional Fund Advisors, Inc. 623.46K Jun 30, 2026 2.71% $0.01 17.37%
American Century Companies Inc 574.47K Jun 30, 2026 2.50% $0.02 199.87%
Arrowstreet Capital Limited Partnership 562.02K Jun 30, 2026 2.45% $0.02 -0.42%
Global Alpha Capital Management Ltd. 558.00K Jun 30, 2026 2.43% $2.77 54.47%
Geode Capital Management, LLC 536.41K Jun 30, 2026 2.34% $0.00 9.65%
Millennium Management LLC 507.21K Jun 30, 2026 2.21% $0.02 -14.33%
Nuveen, LLC 415.02K Jun 30, 2026 1.81% $0.01 3.15%
Vanguard Portfolio Management, LLC 407.28K Jun 30, 2026 1.77% $0.00 8.33%
Ranger Investment Management LP 343.15K Jun 30, 2026 1.49% $1.80 -4.70%
Deutsche Bank AG 323.44K Jun 30, 2026 1.41% $0.01 1.18%
Amvescap Plc. 309.23K Jun 30, 2026 1.35% $0.00 -4.66%
UBS Group AG 297.54K Jun 30, 2026 1.30% $0.00 -40.22%
Kennedy Capital Management Inc 295.94K Jun 30, 2026 1.29% $0.43 0.66%
Ameriprise Financial Inc 287.38K Jun 30, 2026 1.25% $0.00 6.33%
Delaware Management Holdings Inc 287.21K Jun 30, 2026 1.25% $0.04 -0.12%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 1.21M 5.26% ▲ 0.07% Oct 28, 2026
2 Avantis US Small Cap Value ETF 801.92K 3.49% ▲ 0.21% Oct 29, 2026
3 Vanguard MStar Total Stk Mkt Idx Invest 656.41K 2.86% ▲ 6.80% Sep 30, 2026
4 iShares Russell 2000 ETF 515.63K 2.24% ▼ 0.40% Oct 29, 2026
5 CC&L Global Alpha - Series A 279.24K 1.22% ▲ 2.45% Jul 31, 2026
6 Oberweis Micro-Cap 256.30K 1.12% ▲ 20.61% Jun 30, 2026
7 Invesco Pharmaceuticals ETF 233.21K 1.02% ▲ 0.45% Oct 30, 2026
8 Fidelity Small Cap Index 224.19K 0.98% ▲ 0.92% Jul 31, 2026
9 CREF Total Global Stock Account R3 220.01K 0.96% ▲ 7.60% Aug 31, 2026
10 iShares Russell 2000 Growth ETF 192.52K 0.84% ▲ 0.25% Oct 29, 2026

Financial Highlights

▼
Market Cap: $1.65B
EBITDA: $209.41M
P/E Ratio: $15.51
PEG Ratio: $1.78
Book Value: $27.87
Earnings/Share: $4.62
Profit Margin: 11.07%
Operating Margin: 14.97%
ROA (TTM): 5.45%
ROE (TTM): 20.46%
Revenue (TTM): $978.38M
Revenue/Share (TTM): $47.24
Earnings Growth (YOY): 191.10%
Revenue Growth (YOY): 25.90%

Valuation Metrics

Enterprise Value: $1.86B
Trailing P/E: 15.51
Forward P/E: 7.14

Shares Statistics

Shares Outstanding: 22.96M
Shares Float: 19.67M
% Insiders: 5.37%
% Institutions: 107.19%
Shares Short: 3.47M
Shares Short (Prior Month): 3.49M
Short Ratio: 8.21
Short % Float: 18.41%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$883.37M
Cost of Goods Sold
adjust
$-432.73M
Gross Profit
subtotal
$450.64M
SG&A
adjust
$-317.75M
R&D
adjust
$-51.66M
Operating Income
subtotal
$81.23M
Other / Non-Operating Items
adjust
$-2.89M
Net Income
subtotal
$78.34M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ANIP.US!